|
|
||||||||
CORRESPONDENCE: B.J. Currie, Menzies School of Health Research and Northern Territory Clinical School, Flinders University, Darwin, Australia. Fax: 61 889275187. E-mail: bart@menzies.edu.au
Keywords: Burkholderia pseudomallei, cystic fibrosis, epidemiology, melioidosis, pneumonia, septic shock
Received: January 30, 2003
Accepted April 25, 2003
Abstract
Melioidosis is endemic in South East Asia, Asia and northern Australia. Infection usually follows percutaneous inoculation or inhalation of the causative bacterium, Burkholderia pseudomallei, which is present in soil and surface water in the endemic region. While 2036% of melioidosis cases have no evident predisposing risk factor, the vast majority of fatal cases have an identified risk factor, the most important of which are diabetes, alcoholism and chronic renal disease.
Half of all cases present with pneumonia, but there is great clinical diversity, from localised skin ulcers or abscesses without systemic illness to fulminant septic shock with multiple abscesses in the lungs, liver, spleen and kidneys. At least 10% of cases present with a chronic respiratory illness (sick >2 months) mimicking tuberculosis and often with upper lobe infiltrates and/or cavities on chest radiography. As with tuberculosis, latency with reactivation decades after infection can also occur, although this is rare.
Confirmation of diagnosis is by culture of B. pseudomallei from blood, sputum, throat swab or other samples. Microbiology laboratories need to be informed of the possibility of melioidosis, as those not familiar with it can misidentify the organism. Antibiotic therapy is initial intensive therapy with i.v. ceftazidime or meropenem or imipenem +/ cotrimoxazole for
Melioidosis has been increasingly recognised in returning travellers in Europe and recently melioidosis and colonisation with B. pseudomallei have been documented in cystic fibrosis patients visiting or resident in endemic areas.
10 days, followed by eradication therapy with cotrimoxazole +/ doxycycline +/ chloramphenicol (first 4 weeks only) for
3 months.
This article has been cited by other articles:
![]() |
G.-Y. G. Tan, Y. Liu, S. P. Sivalingam, S.-H. Sim, D. Wang, J.-C. Paucod, Y. Gauthier, and E.-E. Ooi Burkholderia pseudomallei aerosol infection results in differential inflammatory responses in BALB/c and C57Bl/6 mice J. Med. Microbiol., April 1, 2008; 57(4): 508 - 515. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. Wiersinga, C. W. Wieland, G. J. W. van der Windt, A. de Boer, S. Florquin, A. Dondorp, N. P. Day, S. J. Peacock, and T. van der Poll Endogenous Interleukin-18 Improves the Early Antimicrobial Host Response in Severe Melioidosis Infect. Immun., August 1, 2007; 75(8): 3739 - 3746. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-P. Su, H.-W. Yang, Y.-L. Chen, T.-L. Ferng, Y.-L. Chou, T.-C. Chung, C.-H. Chen, C.-S. Chiang, M.-M. Kuan, H.-H. Lin, et al. Prevalence of Melioidosis in the Er-Ren River Basin, Taiwan: Implications for Transmission J. Clin. Microbiol., August 1, 2007; 45(8): 2599 - 2603. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sarkar-Tyson, J. E. Thwaite, S. V. Harding, S. J. Smither, P. C. F. Oyston, T. P. Atkins, and R. W. Titball Polysaccharides and virulence of Burkholderia pseudomallei J. Med. Microbiol., August 1, 2007; 56(8): 1005 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
Imported Melioidosis--South Florida, 2005 JAMA, November 1, 2006; 296(17): 2083 - 2085. [Full Text] [PDF] |
||||
![]() |
R. T. Novak, M. B. Glass, J. E. Gee, D. Gal, M. J. Mayo, B. J. Currie, and P. P. Wilkins Development and Evaluation of a Real-Time PCR Assay Targeting the Type III Secretion System of Burkholderia pseudomallei J. Clin. Microbiol., January 1, 2006; 44(1): 85 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. I. T VELD, V. WUTHIEKANUN, A. C. CHENG, W. CHIERAKUL, W. CHAOWAGUL, A. E. BROUWER, N. J. WHITE, N. P. J. DAY, and S. J. PEACOCK THE ROLE AND SIGNIFICANCE OF SPUTUM CULTURES IN THE DIAGNOSIS OF MELIOIDOSIS Am J Trop Med Hyg, October 1, 2005; 73(4): 657 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Cheng and B. J. Currie Melioidosis: Epidemiology, Pathophysiology, and Management Clin. Microbiol. Rev., April 1, 2005; 18(2): 383 - 416. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. GAL, M. MAYO, H. SMITH-VAUGHAN, P. DASARI, M. MCKINNON, S. P. JACUPS, A. I. URQUHART, M. HASSELL, and B. J. CURRIE CONTAMINATION OF HAND WASH DETERGENT LINKED TO OCCUPATIONALLY ACQUIRED MELIOIDOSIS Am J Trop Med Hyg, September 1, 2004; 71(3): 360 - 362. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O'Brien, K. Freeman, G. Lum, A. C. Cheng, S. P. Jacups, and B. J. Currie Further Evaluation of a Rapid Diagnostic Test for Melioidosis in an Area of Endemicity J. Clin. Microbiol., May 1, 2004; 42(5): 2239 - 2240. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |